-
公开(公告)号:US20220169630A1
公开(公告)日:2022-06-02
申请号:US17546284
申请日:2021-12-09
Applicant: NOVARTIS AG
Inventor: Peng FU , Yu GAI , Feng GAO , Weiyong KONG , Yadong LU , Zhongcheng MIN , Shaofeng RONG , Chutian SHU , Can WANG , Ruidong WANG , Jibin ZHAO , Xianglin ZHAO , Yi ZHAO , Jianguang ZHOU , Benjamin MARTIN
IPC: C07D401/06 , C07D209/04 , C07D211/74
Abstract: The present invention relates to a method of synthesizing a compound of formula (I) also referred to as 4-(((2S,4S)-(4-ethoxy-1-(((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl))benzoic acid, or a pharmaceutically acceptable salt thereof, and/or intermediates thereof, their use as pharmaceuticals and pharmaceutical compositions and the use of intermediates for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20210269416A1
公开(公告)日:2021-09-02
申请号:US17260393
申请日:2019-07-15
Applicant: NOVARTIS AG
Inventor: Peng FU , Yu GAI , Feng GAO , Weiyong KONG , Yadong LU , Zhongcheng MIN , Shaofeng RONG , Chutian SHU , Can WANG , Ruidong WANG , Jibin ZHAO , Xianglin ZHAO , Yi ZHAO , Jianguang ZHOU , Benjamin MARTIN
IPC: C07D401/06 , C07D211/74 , C07D209/04
Abstract: The present invention relates to a method of synthesizing a compound of formula (I) also referred to as 4-((2S,4S)-(4-ethoxy-1-((5-methoxy-7-methyl-1/-/-indol-4-yl)methyl)piperidin-2-yl))benzoic acid, or a pharmaceutically acceptable salt thereof, and/or intermediates thereof, their use as pharmaceuticals and pharmaceutical compositions and the use of intermediates for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20230348420A1
公开(公告)日:2023-11-02
申请号:US18002291
申请日:2021-06-24
Applicant: Novartis AG
Inventor: Nicolas AMIOT , Darija DEDIC , Peng FU , Fabrice GALLOU , Xingxian GU , Cornelius HARLACHER , Siqian LIU , Shuping YAO , Jiong YE , Jianguang ZHOU
IPC: C07D401/12 , C07D401/14 , C07D237/08 , C07D231/14
CPC classification number: C07D401/12 , C07D401/14 , C07D237/08 , C07D231/14
Abstract: The invention relates to a novel process, novel process step(s) and novel intermediate(s) useful for the preparation of 1,4-disubstituted pyridazine compounds, such as 5-(1H-Pyrazol-4-yl)-2-(6-((2,2,6,6-tetramethylpiperidin-4-yl)oxy)pyridazin-3-yl)phenol.
-
-